Achieve Life Sciences Inc

Stock Chart, Company Information, and Scan Results

$2.54(as of Aug 13, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Achieve Life Sciences Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$2.54
Ticker SymbolACHV
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees25
CountyUSA
Market Cap$124.7M

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Achieve Life Sciences Inc In Our Stock Scanner

As of Aug 14, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.